LRRK2-targeted Parkinson disease drug advances into phase III
Katie Kingwell
Topics & Concepts
LRRK2DiseaseDrugMedicineParkinson's diseaseDrug trialKinaseDrug developmentClinical trialPharmacologyInternal medicineBiologyGeneticsPhytochemistry and biological activities of Ficus speciesParkinson's Disease Mechanisms and TreatmentsFungal Plant Pathogen Control